(Refeed) NOVA Short | Chemotherapy and Breast Cancer

It used to be standard practice that all patients received chemotherapy after surgery to prevent the recurrence of breast cancer. Today, a genetic test called Oncotype DX allows doctors to analyze the genome of a patient's cancer cells. The results can help oncologists determine whether a patient actually needs to endure chemotherapy post-surgery, thereby avoiding needless suffering. NOVA is produced by WGBH in Boston. National corporate funding for NOVA is provided by The Boeing Company. Major funding for NOVA is provided by David H. Koch, the Corporation for Public Broadcasting, and PBS viewers.